View in EDS HTML Full Text PDF Full Text

Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2.

Saved in:
Bibliographic Details
Title: Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2.
Authors: He J; Department of Breast Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China., Wang J; Department of Breast Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China., Li S; Department of Urology Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China., Li T; Department of Urology Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China., Chen K; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China., Zhang S; Department of Urology Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
Source: Cancer science [Cancer Sci] 2020 Oct; Vol. 111 (10), pp. 3550-3563. Date of Electronic Publication: 2020 Aug 13.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32726486
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22He+J%22">He J</searchLink>; Department of Breast Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Department of Breast Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Li+S%22">Li S</searchLink>; Department of Urology Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Li+T%22">Li T</searchLink>; Department of Urology Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Chen+K%22">Chen K</searchLink>; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhang+S%22">Zhang S</searchLink>; Department of Urology Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101168776%22">Cancer science</searchLink> [Cancer Sci] 2020 Oct; Vol. 111 (10), pp. 3550-3563. <i>Date of Electronic Publication: </i>2020 Aug 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley+Publishing+on+behalf+of+the+Japanese+Cancer+Association%22">Wiley Publishing on behalf of the Japanese Cancer Association </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101168776 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1349-7006 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213479032%22">13479032 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Sci <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32726486
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/cas.14589
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3550
    Titles:
      – TitleFull: Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: He J
      – PersonEntity:
          Name:
            NameFull: Wang J
      – PersonEntity:
          Name:
            NameFull: Li S
      – PersonEntity:
          Name:
            NameFull: Li T
      – PersonEntity:
          Name:
            NameFull: Chen K
      – PersonEntity:
          Name:
            NameFull: Zhang S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2020 Oct
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1349-7006
          Numbering:
            – Type: volume
              Value: 111
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Cancer science
              Type: main
ResultId 1